Home/Filings/4/0001549595-24-000065
4//SEC Filing

Reinsdorf Judith A 4

Accession 0001549595-24-000065

CIK 0001549595other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 7:25 PM ET

Size

5.5 KB

Accession

0001549595-24-000065

Insider Transaction Report

Form 4
Period: 2024-05-20
Transactions
  • Award

    Director Stock Option (right to buy)

    2024-05-20+25,00025,000 total
    Exercise: $16.19Exp: 2034-05-19Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 20, 2025, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001305361

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:25 PM ET
Size
5.5 KB